The biomedical technology program seeks to increase small business participation in federally supported research and development as well as the private-sector commercialization of technology developed with federal support. It does this through the federal government's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
The program supports projects in which the primary focus is technology research and development, with special interest in funding research in such areas as:
- New or improved instruments, devices and related methods to facilitate biomedical or behavioral research. Instrumentation includes but is not limited to mass spectrometry, nuclear magnetic resonance, imaging, fluorescent or kinetic or laser spectroscopy, X-ray absorption/diffraction, detector technology, electron or confocal microscopy and flow cytometry.
- Computer science and technology designed to study biomedical or behavioral research problems, such as computer modeling, simulation and structure-based drug design.
- The development of computational infrastructures that enable the sharing, visualization and modeling of biomedical data and the integration of data from heterogeneous sources.
- Novel technologies for proteomics and glycomics discovery, such as sample handing, separations, mass spectrometry and computational tools for protein identification, data curation and data mining.
For more information about NIGMS support of small business opportunities in biomedical technology, contact:
Mary Ann Wu, Ph.D.
Division of Biomedical Technology, Bioinformatics, and Computational Biology
National Institute of General Medical Sciences
National Institutes of Health
45 Center Drive MSC 6200
Bethesda, MD 20892-6200